{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:51:46Z","timestamp":1760953906565,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.critrevonc.2020.102876","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T11:46:25Z","timestamp":1579520785000},"page":"102876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Oral contraceptives and breast cancer risk: An overestimated risk?"],"prefix":"10.1016","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2950-3395","authenticated-orcid":false,"given":"Gianluca","family":"Franceschini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Di Leone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabatino","family":"D\u2019Archi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Masetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"May","key":"10.1016\/j.critrevonc.2020.102876_bib0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.critrevonc.2019.03.001","article-title":"Breast cancer risk of hormonal contraception: counselling considering new evidence","volume":"137","author":"Del Pup","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"October (4)","key":"10.1016\/j.critrevonc.2020.102876_bib0010","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/AOG.0b013e31826af61a","article-title":"False alarms and pseudo-epidemics: the limitations of observational epidemiology","volume":"120","author":"Grimes","year":"2012","journal-title":"Obstet. Gynecol."},{"issue":"September (36)","key":"10.1016\/j.critrevonc.2020.102876_bib0015","doi-asserted-by":"crossref","first-page":"e15719","DOI":"10.1097\/MD.0000000000015719","article-title":"Effect of age at first use of oral contraceptives on breast cancer risk: an updated meta-analysis","volume":"98","author":"Ji","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.critrevonc.2020.102876_bib0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3904\/kjm.2019.94.5.391","article-title":"Strengths and limitations of meta-analysis","volume":"94","author":"Lee","year":"2019","journal-title":"Korean J. Med."},{"issue":"July (1)","key":"10.1016\/j.critrevonc.2020.102876_bib0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3892\/mco.2017.1259","article-title":"Association between oral contraceptive use as a risk factor and triple-negative breast cancer: a systematic review and meta-analysis","volume":"7","author":"Li","year":"2017","journal-title":"Mol. Clin. Oncol."},{"issue":"December (23)","key":"10.1016\/j.critrevonc.2020.102876_bib0030","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary hormonal contraception and the risk of breast cancer","volume":"377","author":"M\u00f8rch","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"33","key":"10.1016\/j.critrevonc.2020.102876_bib0035","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1200\/JCO.2013.48.9021","article-title":"Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis","volume":"31","author":"Moorman","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"May (5)","key":"10.1016\/j.critrevonc.2020.102876_bib0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jogoh.2019.02.006","article-title":"Update on the contraceptive contraindications","volume":"48","author":"Serfaty","year":"2019","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"issue":"December (4)","key":"10.1016\/j.critrevonc.2020.102876_bib0045","doi-asserted-by":"crossref","first-page":"294","DOI":"10.15430\/JCP.2016.21.4.294","article-title":"The role of oral contraceptive pills on increased risk of breast cancer in Iranian populations: a meta-analysis","volume":"21","author":"Soroush","year":"2016","journal-title":"J. Cancer Prev."},{"issue":"June (6)","key":"10.1016\/j.critrevonc.2020.102876_bib0050","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3949\/ccjm.75.6.431","article-title":"Meta-analysis: its strengths and limitations","volume":"75","author":"Walker","year":"2008","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.critrevonc.2020.102876_bib0055","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3109\/13625187.2012.715357","article-title":"Oral contraceptive use and risk of breast cancer: a meta-analysis of prospective cohort studies","volume":"17","author":"Zhu","year":"2012","journal-title":"Eur. J. Contracept. Reprod. Health Care"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842820300147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842820300147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:32:41Z","timestamp":1760902361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842820300147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":11,"alternative-id":["S1040842820300147"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2020.102876","relation":{},"ISSN":["1040-8428"],"issn-type":[{"type":"print","value":"1040-8428"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral contraceptives and breast cancer risk: An overestimated risk?","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2020.102876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102876"}}